STOK ▼ -0.2% - Stoke Therapeutics, Inc.
$STOK reported Q3 2026 EPS of -$1.08, missing the -$0.91 estimate by 18.7%. Revenue of $11.3M beat the $8.2M estimate by 37.2%.
29-OCT-2026 04:09 PM ET
Share this post
More filings for $STOK
STOK ▼ -0.1% - Stoke Therapeutics, Inc.Oct 6, 2026STOK - Stoke Therapeutics, Inc. - SEC Filing Update (30-SEP-2026) | ThinkSabio - Stocks SimplifiedSep 30, 2026STOK ▼ -9.4% - Stoke Therapeutics, Inc.Sep 23, 2026STOK ▲ +0.8% - Stoke Therapeutics, Inc.Sep 1, 2026STOK - Stoke Therapeutics, Inc. - SEC Filing Update (06-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 6, 2026
View full $STOK filing history →💬 Comments
Loading comments…
Leave a comment